#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary myelofibrosis Sickle cell disease Malignant central nervous system neoplasm Philadelphia positive acute lymphocytic leukaemia Granulomatosis with polyangiitis Chronic graft versus host disease in skin Hairy cell leukaemia Behcet's syndrome Congenital ectodermal dysplasia Plasma cell myeloma recurrent Systemic mastocytosis Cholestatic pruritus Polycythaemia vera Chronic myeloid leukaemia Autoimmune hepatitis More trials…

    Learn about Rare Diseases

    Crigler-Najjar syndrome – Diagnostics Marginal zone lymphoma Hereditary neuropathic amyloidosis – Treatment Urea cycle disorder – Diagnostics Hyperoxaluria Ewing’s sarcoma recurrent – Trials in Disease Mucous membrane pemphigoid – Life with Disease Epidermolysis bullosa – Diagnostics SAPHO syndrome – Basic Information Burkitt’s lymphoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elexacaftor Ustekinumab ASP2957 Gadoquatrane Lixudebart 204-NETU Escitalopram 177Lu-Dpi-4452 Elinzanetant L-Ascorbic Acid Progesterone Acetylcholine Chloride Utreglutide Deferiprone Efruxifermin Linaclotide Tomligisiran Ecoo25B Poltreg-T1D Relebactam More therapies…

    Learn about Your Condition

    Oedema Streptococcal infection Mumps Upper limb fracture Cancer pain Primary biliary cholangitis Pouchitis Hypothyroidism Alopecia areata Craniotomy Large cell lung cancer Polymyositis Oesophagogastroscopy Fallopian tube cancer Compulsive sexual behaviour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colorectal cancer

  • Study of DKN-01 with Drug Combination for Patients with Advanced Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Sirexatamab
    • Bevacizumab
    • Calcium Folinate
    Germany

  • Study of Flu Vaccine and Pembrolizumab for Patients with Early Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • A/Victoria/2570/2019 (H1N1)Pdm09-Like Strain (A/Victoria/2570/2019, Ivr-215)
    • B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type)
    • Influenza A Virus/Thailand/8/2022 (H3N2)-Like Strain (A/California/122/2022, San-022), Inactivated
    Denmark

  • Study of Subcutaneous Nivolumab with or without Recombinant Human Hyaluronidase PH20 for Patients with Lung, Kidney, Melanoma, Liver, Colorectal, or Bladder Cancer

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Nivolumab
    France Italy The Netherlands Poland Spain

  • Study on the Effectiveness of Ompenaclid with FOLFIRI and Bevacizumab for Patients with Advanced or Metastatic Colorectal Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Rgx-202
    • Bevacizumab
    • Irinotecan
    Belgium France Spain

  • Study on Vitamin D3 and Glycerol for Reducing Fatigue in Colorectal Cancer Patients with Low Vitamin D Levels After Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Colecalciferol
    • Glycerol
    Germany
Previous Page
1 … 13 14 15

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!